Clinical Trials Browser

Interventional × Advanced Gastrointestinal Tumors × Bevacizumab × Clear all

NCT01916447 2024-09-05

A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.

Phase 1 Completed

Gastrointestinal

Advanced Gastrointestinal Tumors